SCHEMBL1300301

SCHEMBL1300301

CC/C=C/C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1569417 1.00
SCHEMBL13611576 0.81
SCHEMBL13611577 0.79 PPARA (0.42)
SCHEMBL11838860 0.78
SCHEMBL898579 0.78
SCHEMBL898577 0.78
SCHEMBL31339493 0.77
SCHEMBL16181330 0.75 ALDH1A1 (0.39)
SCHEMBL9593302 0.75 ALDH1A1 (0.39)
SCHEMBL182648 0.75 ALDH1A1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 182 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119684764-A Crystalline polyester heat-shrinkable film easy to recycle, and preparation method and recycling application thereof 河南银金达新材料股份有限公司 2025-03-25 CN claimed
CN-119409902-A Special polycarboxylate superplasticizer for lithium slag and preparation method thereof 中建西部建设新材料科技有限公司 2025-02-11 CN claimed
CN-118290659-A High-temperature-resistant flame-retardant polyurethane foam material 万华化学集团股份有限公司 2024-07-05 CN claimed
CN-117843882-A Polycarboxylate superplasticizer special for UHPC and preparation method thereof 江西万华环保材料有限公司 2024-04-09 CN claimed
CN-117362507-A Super macroporous hydrophilic microsphere and preparation method thereof 青岛科诺赛生物科技有限公司 2024-01-09 CN claimed
CN-103391776-B Novel compounds useful in the treatment of cancer and other diseases 太平洋艾瑞有限公司 2023-11-28 CN claimed
CN-111040003-B Chitosan oligosaccharide derivative molecular imprinting functional monomer and preparation method thereof 扬州工业职业技术学院 2023-03-14 CN claimed
CN-115703724-A Sulfonic acid compound, instant temperature-resistant salt-resistant polyacrylamide for oil displacement, and preparation method and application thereof 中国石油化工股份有限公司 2023-02-17 CN claimed
CN-111748060-B Preparation method of polycarboxylate superplasticizer with high viscosity reduction performance 武汉源锦建材科技有限公司 2022-12-30 CN claimed
CN-114835771-A Novel compounds useful for the treatment of cancer and other diseases 太平洋艾瑞有限公司 2022-08-02 CN claimed
CN-111175360-B Preparation method of Sudan red-I molecularly imprinted sensor based on secondary polymerization 扬州工业职业技术学院 2022-03-04 CN claimed
CN-108033941-B Acrylate derivative of spiro [ fluorene-9, 9' -xanthene ] -3',6' -diphenol and preparation method thereof 常州南京大学高新技术研究院 2021-10-22 CN claimed
JP-2011526420-A 2011-10-06 JP claimed
US-20110130522-A1 POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES UNIVERSITEIT HASSELT (BE) 2011-06-02 US claimed
EP-2307398-A1 POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES IMEC (BE) 2011-04-13 EP claimed
WO-2010000504-A1 POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM (BE) 2010-01-07 WO claimed
EP-0640580-B1 Preparation of 3-pentenoic acid and a catalyst therefor DU PONT (US) 1999-03-03 EP claimed
EP-0640580-A1 Preparation of 3-pentenoic acid and a catalyst therefore E.I. DU PONT DE NEMOURS AND COMPANY (US) 1995-03-01 EP claimed
US-5288903-A Catalytic reaction of chlorobutenes with carbon monoxide to pentenoyl chloride; forming palladium catalyst; reacting with butadiene, water to acid E. I. DU PONT DE NEMOURS AND COMPANY (US) 1994-02-22 US claimed
CN-119954674-A Polyacrylonitrile comonomer and application thereof in preparation of PAN-based carbon fiber with high carbon forming rate 深圳大学 2025-05-09 CN disclosed
CN-119684764-A Crystalline polyester heat-shrinkable film easy to recycle, and preparation method and recycling application thereof 河南银金达新材料股份有限公司 2025-03-25 CN disclosed
CN-119186219-B Ammonia desulfurization method capable of remarkably reducing ammonia escape and application thereof 山东明晟环保科技有限公司 2025-02-25 CN disclosed
CN-114671923-B Novel compounds useful in the treatment of cancer and other diseases 太平洋艾瑞有限公司 2025-02-11 CN disclosed
CN-119409902-A Special polycarboxylate superplasticizer for lithium slag and preparation method thereof 中建西部建设新材料科技有限公司 2025-02-11 CN disclosed
WO-2025000060-A1 BIO-MONOMERS, POLYMERS AND METHODS OF PREPARING THE SAME UNIVERSITY OF TASMANIA (AU) 2025-01-02 WO disclosed
CN-119186219-A Ammonia desulfurization method capable of remarkably reducing ammonia escape and application thereof 山东明晟环保科技有限公司 2024-12-27 CN disclosed
CN-114835771-B Novel compounds useful in the treatment of cancer and other diseases 太平洋艾瑞有限公司 2024-12-03 CN disclosed
CN-118290659-A High-temperature-resistant flame-retardant polyurethane foam material 万华化学集团股份有限公司 2024-07-05 CN disclosed
CN-117843590-A 3-amino-4- (piperazin-1-yl) benzamide derivative, pharmaceutical composition containing same, and preparation method and application thereof 中国药科大学 2024-04-09 CN disclosed
CN-117843882-A Polycarboxylate superplasticizer special for UHPC and preparation method thereof 江西万华环保材料有限公司 2024-04-09 CN disclosed
CN-115703724-B Sulfonic acid compound, instant type heat-resistant salt-resistant polyacrylamide for oil displacement, and preparation method and application thereof 中国石油化工股份有限公司 2024-02-13 CN disclosed
CN-117362507-A Super macroporous hydrophilic microsphere and preparation method thereof 青岛科诺赛生物科技有限公司 2024-01-09 CN disclosed
CN-103391776-B Novel compounds useful in the treatment of cancer and other diseases 太平洋艾瑞有限公司 2023-11-28 CN disclosed
CN-113527079-B Method for preparing 2-isopropenyl-5-methyl-4-hexenoic acid and derivative alcohol and carboxylic ester thereof 信越化学工业株式会社 2023-11-14 CN disclosed
CN-117004044-A Polymer microsphere emulsion for profile control and flooding as well as preparation method and application thereof 江西炼石环保科技有限公司 2023-11-07 CN disclosed
US-20230340012-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2023-10-26 US disclosed
US-20230340012-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2023-10-26 US disclosed
US-20230340012-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2023-10-26 US disclosed
US-20230159436-A1 APPLICATIONS OF AMIDE ANALOGS OF TRITERPENES IN CURES OF CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2023-05-25 US disclosed
US-20230159436-A1 APPLICATIONS OF AMIDE ANALOGS OF TRITERPENES IN CURES OF CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2023-05-25 US disclosed
CN-111040003-B Chitosan oligosaccharide derivative molecular imprinting functional monomer and preparation method thereof 扬州工业职业技术学院 2023-03-14 CN disclosed
CN-111040003-B Chitosan oligosaccharide derivative molecular imprinting functional monomer and preparation method thereof 扬州工业职业技术学院 2023-03-14 CN disclosed
CN-115703724-A Sulfonic acid compound, instant temperature-resistant salt-resistant polyacrylamide for oil displacement, and preparation method and application thereof 中国石油化工股份有限公司 2023-02-17 CN disclosed
EP-3901125-B1 PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF SHINETSU CHEMICAL CO (JP) 2023-01-18 EP disclosed
CN-111748060-B Preparation method of polycarboxylate superplasticizer with high viscosity reduction performance 武汉源锦建材科技有限公司 2022-12-30 CN disclosed
US-11485755-B2 Natural and synthetic compounds for treating cancer and other diseases PACIFIC ARROW LTD (CN) 2022-11-01 US disclosed
CN-115197293-A Novel compounds useful for the treatment of cancer and other diseases 太平洋艾瑞有限公司 2022-10-18 CN disclosed
CN-114835771-A Novel compounds useful for the treatment of cancer and other diseases 太平洋艾瑞有限公司 2022-08-02 CN disclosed
CN-114671923-A Novel compounds useful for the treatment of cancer and other diseases 太平洋艾瑞有限公司 2022-06-28 CN disclosed
CN-110295400-B Dehumidifying and breathable sports knitted fabric and preparation method thereof 同创生活科技(深圳)有限公司 2022-06-24 CN disclosed
US-11305018-B2 Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures VANDERBILT UNIVERSITY (US) 2022-04-19 US disclosed
US-11286227-B2 Processes for preparing 2-isopropenyl-5-methyl-4-hexenoic acid, 2-isopropenyl-5-methyl-4-hexen-1-ol, and a carboxylate ester thereof SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-03-29 US disclosed
CN-111175360-B Preparation method of Sudan red-I molecularly imprinted sensor based on secondary polymerization 扬州工业职业技术学院 2022-03-04 CN disclosed
CN-109641908-B Five-membered heterocyclic [3,4-d ] pyridazinone compound, preparation method thereof, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2021-11-19 CN disclosed
EP-3901125-A1 PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF Shin-Etsu Chemical Co., Ltd. (JP) 2021-10-27 EP disclosed
CN-108033941-B Acrylate derivative of spiro [ fluorene-9, 9' -xanthene ] -3',6' -diphenol and preparation method thereof 常州南京大学高新技术研究院 2021-10-22 CN disclosed
CN-113527079-A Method for preparing 2-isopropenyl-5-methyl-4-hexenoic acid and derivative alcohol and carboxylic ester thereof 信越化学工业株式会社 2021-10-22 CN disclosed
US-20210323902-A1 PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-10-21 US disclosed
US-20200199172-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2020-06-25 US disclosed
US-20200199172-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2020-06-25 US disclosed
US-10590163-B2 Natural and synthetic compounds for treating cancer and other diseases PACIFIC ARROW LIMITED (CN) 2020-03-17 US disclosed
US-20190135818-A1 5-MEMBERED HETEROCYCLE FUSED WITH [3,4-D] PYRIDAZINONE, AND MANUFACTURING METHOD, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2019-05-09 US disclosed
EP-3470415-A1 5-MEMBERED HETEROCYCLE FUSED WITH [3,4-D]PYRIDAZINONE, AND MANUFACTURING METHOD, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2019-04-17 EP disclosed
US-20170267714-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2017-09-21 US disclosed
US-20170267714-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2017-09-21 US disclosed
US-9694086-B2 HCV protease inhibitors and uses thereof CELGENE CAR LLC (BM) 2017-07-04 US disclosed
EP-3147285-A2 PURINONE COMPOUNDS AS KINASE INHIBITORS Pharmacyclics, Inc. (US) 2017-03-29 EP disclosed
EP-2621923-B1 N-HETEROARYL COMPOUNDS WITH CYCLIC BRIDGING UNIT FOR THE TREATMENT OF PARASITIC DISEASES INTERVET INT BV (NL) 2017-03-29 EP disclosed
EP-2612860-B1 QUINAZOLINE DERIVATIVES SUBSTITUTED BY ANILINE, PREPARATION METHOD AND USE THEREOF XUANZHU PHARMA CO LTD (CN) 2017-03-15 EP disclosed
US-20170022246-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2017-01-26 US disclosed
US-20170022246-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2017-01-26 US disclosed
US-20170022246-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2017-01-26 US disclosed
US-9499577-B2 Natural and synthetic compounds for treating cancer and other diseases PACIFIC ARROW LTD (CN) 2016-11-22 US disclosed
US-9434677-B2 Natural and synthetic compounds for treating cancer and other diseases PACIFIC ARROW LIMITED (HK) 2016-09-06 US disclosed
US-20160243249-A1 HCV PROTEASE INHIBITORS AND USES THEREOF CELGENE CAR LLC (BM) 2016-08-25 US disclosed
US-20160235805-A1 HCV PROTEASE INHIBITORS AND USES THEREOF CELGENE CAR LLC (BM) 2016-08-18 US disclosed
US-9353062-B2 Substituted quinolines as bruton's tyrosine kinases inhibitors HANGZHOUDERENYUCHENG BIOTECHNOLOGY LTD (CN) 2016-05-31 US disclosed
US-20160102047-A1 SUBSTITUTED N-PENTANAMIDE COMPOUNDS, PREPARATION METHOD AND THE USE THEREOF TOPHARMAN SHANGHAI CO., LTD. (CN) 2016-04-14 US disclosed
US-9249084-B2 Substituted n-pentanamide compounds, preparation method and the use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2016-02-02 US disclosed
EP-2522367-B1 Oligomer-protease inhibitor conjugates NEKTAR THERAPEUTICS (US) 2016-01-20 EP disclosed
EP-2522367-B1 Oligomer-protease inhibitor conjugates NEKTAR THERAPEUTICS (US) 2016-01-20 EP disclosed
WO-2015154039-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) SYROS PHARMACEUTICALS, INC. (US) 2015-10-08 WO disclosed
US-9107956-B2 Oligomer-protease inhibitor conjugates NEKTAR THERAPEUTICS (US) 2015-08-18 US disclosed
US-9107956-B2 Oligomer-protease inhibitor conjugates NEKTAR THERAPEUTICS (US) 2015-08-18 US disclosed
US-9107956-B2 Oligomer-protease inhibitor conjugates NEKTAR THERAPEUTICS (US) 2015-08-18 US disclosed
US-20150057312-A1 SUBSTITUTED QUINOLINES AS BRUTON'S TYROSINE KINASES INHIBITORS HANGZHOUDERENYUCHENG BIOTECHNOLOGY LTD (CN) 2015-02-26 US disclosed
EP-2131865-B1 OLIGOMER-PROTEASE INHIBITOR CONJUGATES NEKTAR THERAPEUTICS (US) 2014-12-17 EP disclosed
EP-2131865-B1 OLIGOMER-PROTEASE INHIBITOR CONJUGATES NEKTAR THERAPEUTICS (US) 2014-12-17 EP disclosed
US-8883791-B2 N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases INTERVET INC. (US) 2014-11-11 US disclosed
US-20140322810-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2014-10-30 US disclosed
US-8785646-B2 Process for producing amide compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-07-22 US disclosed
US-20140199378-A1 NEW NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LIMITED (CN) 2014-07-17 US disclosed
CN-103857399-A New natural and synthetic compounds for treating cancer and other diseases PACIFIC ARROW LTD 2014-06-11 CN disclosed
US-20140045770-A1 OLIGOMER-PROTEASE INHIBITOR CONJUGATES NEKTAR THERAPEUTICS (US) 2014-02-13 US disclosed
US-20140045770-A1 OLIGOMER-PROTEASE INHIBITOR CONJUGATES NEKTAR THERAPEUTICS (US) 2014-02-13 US disclosed
US-20140045770-A1 OLIGOMER-PROTEASE INHIBITOR CONJUGATES NEKTAR THERAPEUTICS (US) 2014-02-13 US disclosed
US-20140046074-A1 Substituted n-pentanamide compounds, preparation method and the use thereof TOPHARMAN SHANGHAI CO., LTD. (CN) 2014-02-13 US disclosed
EP-2671878-A1 SUBSTITUTED N-PENTANAMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF Shanghai Institute Materia Medica, Chinese Academy Of Sciences (CN) 2013-12-11 EP disclosed
US-8598364-B2 Oligomer-protease inhibitor conjugates NEKTAR THERAPEUTICS (US) 2013-12-03 US disclosed
US-8541613-B2 Process for producing amide compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-09-24 US disclosed
CN-101622264-B Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions EVONIK DEGUSSA GMBH 2013-09-18 CN disclosed
US-8524722-B2 Substituted tricyclic compounds and methods of use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-09-03 US disclosed
US-20130203768-A1 N-HETEROARYL COMPOUNDS WITH CYCLIC BRIDGING UNIT FOR THE TREATMENT OF PARASITIC DISEASES INTERVET INC. 2013-08-08 US disclosed
US-8501951-B2 Process for producing amide compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-08-06 US disclosed
US-8450604-B2 Polymerisable compounds for making opto-electronic devices IMEC (BE) 2013-05-28 US disclosed
US-20130131371-A1 PROCESS FOR PRODUCING AMIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-05-23 US disclosed
US-20130131348-A1 PROCESS FOR PRODUCING AMIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-05-23 US disclosed
US-20130131105-A1 HCV PROTEASE INHIBITORS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2013-05-23 US disclosed
US-20130131349-A1 PROCESS FOR PRODUCING AMIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-05-23 US disclosed
US-8394838-B2 Process for producing amide compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-03-12 US disclosed
WO-2013012737-A1 NEW NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LIMITED (VG) 2013-01-24 WO disclosed
EP-2522367-A1 Oligomer-protease inhibitor conjugates Nektar Therapeutics (US) 2012-11-14 EP disclosed
EP-2522367-A1 Oligomer-protease inhibitor conjugates Nektar Therapeutics (US) 2012-11-14 EP disclosed
US-8304468-B2 Polymers comprising thioester bonds DSM IP ASSETS B.V. (NL) 2012-11-06 US disclosed
EP-2307398-B1 POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES IMEC (BE) 2012-09-05 EP disclosed
US-8119811-B2 Method for producing amide compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-21 US disclosed
US-20110301288-A1 THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS DSM IP ASSETS B.V. (NL) 2011-12-08 US disclosed
US-20110269677-A1 Oligomer-Protease Inhibitor Conjugates NEKTAR THERAPEUTICS (US) 2011-11-03 US disclosed
US-20110269677-A1 Oligomer-Protease Inhibitor Conjugates NEKTAR THERAPEUTICS (US) 2011-11-03 US disclosed
US-20110269677-A1 Oligomer-Protease Inhibitor Conjugates NEKTAR THERAPEUTICS (US) 2011-11-03 US disclosed
EP-2358668-A1 THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS DSM IP Assets B.V. (NL) 2011-08-24 EP disclosed
US-20110158910-A1 MICROPARTICLES COMPRISING POLYMERS WITH THIOESTER BONDS DSM IP ASSETS B.V. (NL) 2011-06-30 US disclosed
US-20110130522-A1 POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES UNIVERSITEIT HASSELT (BE) 2011-06-02 US disclosed
EP-2307398-A1 POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES IMEC (BE) 2011-04-13 EP disclosed
US-20110021493-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-01-27 US disclosed
EP-2265262-A1 PARTICLES COMPRISING POLYMERS WITH THIOESTER BONDS DSM IP Assets B.V. (NL) 2010-12-29 EP disclosed
WO-2010136604-A1 TRANSFER MATRIX FOR TRANSFERRING A BIOACTIVE AGENT TO BODY TISSUE DSM IP ASSETS B.V. (NL) 2010-12-02 WO disclosed
US-20100184989-A1 De Novo Synthesis of Conjugates NEKTAR THERAPEUTICS (US) 2010-07-22 US disclosed
US-20100184989-A1 De Novo Synthesis of Conjugates NEKTAR THERAPEUTICS (US) 2010-07-22 US disclosed
US-20100184989-A1 De Novo Synthesis of Conjugates NEKTAR THERAPEUTICS (US) 2010-07-22 US disclosed
WO-2010070132-A1 THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS DSM IP ASSETS B.V. (NL) 2010-06-24 WO disclosed
US-20100120866-A1 PROCESS FOR PRODUCING AMIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-13 US disclosed
US-20100113794-A1 METHOD FOR PRODUCING AMIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-06 US disclosed
US-20100063310-A1 Functionalized silicon compounds KNEPPER JEFFREY A 2010-03-11 US disclosed
WO-2010000504-A1 POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM (BE) 2010-01-07 WO disclosed
CN-101622264-A Novel cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions EVONIK DEGUSSA GMBH 2010-01-06 CN disclosed
EP-2131865-A2 OLIGOMER-PROTEASE INHIBITOR CONJUGATES Nektar Therapeutics (US) 2009-12-16 EP disclosed
EP-2125027-A2 DE NOVO SYNTHESIS OF CONJUGATES Nektar Therapeutics (US) 2009-12-02 EP disclosed
WO-2009130332-A1 PARTICLES COMPRISING POLYMERS WITH THIOESTER BONDS DSM IP ASSETS B.V. (NL) 2009-10-29 WO disclosed
US-20090156707-A1 Polymers comprising thioester bonds DSM IP ASSETS B.V. (NL) 2009-06-18 US disclosed
US-7482313-B2 Bicyclo(3.3.1)nonanes and bicyclo(3.3.1)nonenes and their use as flavor or fragrance ingredient GIVAUDAN SA (CH) 2009-01-27 US disclosed
WO-2008112286-A9 DE NOVO SYNTHESIS OF CONJUGATES NEKTAR THERAPEUTICS AL CORP (US) 2008-12-18 WO disclosed
WO-2008112286-A9 DE NOVO SYNTHESIS OF CONJUGATES NEKTAR THERAPEUTICS AL CORP (US) 2008-12-18 WO disclosed
US-20080274927-A1 Bicyclo(3.3.1)Nonanes and Bicyclo(3.3.1)Nonenes and Their Use as Flavor or Fragrance Ingredient GIVAUDAN SA (CH) 2008-11-06 US disclosed
WO-2008112286-A2 DE NOVO SYNTHESIS OF CONJUGATES NEKTAR THERAPEUTICS (US) 2008-09-18 WO disclosed
WO-2008112286-A2 DE NOVO SYNTHESIS OF CONJUGATES NEKTAR THERAPEUTICS (US) 2008-09-18 WO disclosed
WO-2008112289-A2 OLIGOMER-PROTEASE INHIBITOR CONJUGATES NEKTAR THERAPEUTICS (US) 2008-09-18 WO disclosed
WO-2008112289-A2 OLIGOMER-PROTEASE INHIBITOR CONJUGATES NEKTAR THERAPEUTICS (US) 2008-09-18 WO disclosed
EP-1922351-A1 POLYMERS COMPRISING THIOESTER BONDS DSMIP Assets B.V. (NL) 2008-05-21 EP disclosed
EP-1706366-B1 BICYCLO[3.3.1]NONANES AND BICYCLO[3.3.1ßNONENES AND THEIR USE AS FLAVOUR OR FRAGRANCE INGREDIENT GIVAUDAN SA (CH) 2008-02-27 EP disclosed
WO-2007028612-A1 POLYMERS COMPRISING THIOESTER BONDS DSM IP ASSETS B.V. (NL) 2007-03-15 WO disclosed
US-7172749-B2 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2007-02-06 US disclosed
EP-1706366-A1 BICYCLO[3.3.1]NONANES AND BICYCLO[3.3.1ßNONENES AND THEIR USE AS FLAVOUR OR FRAGRANCE INGREDIENT Givaudan SA (CH) 2006-10-04 EP disclosed
WO-2005070860-A1 BICYCLO[3.3.1]NONANES AND BICYCLO[3.3.1]NONENES AND THEIR USE AS FLAVOUR OR FRAGRANCE INGREDIENT GIVAUDAN SA (CH) 2005-08-04 WO disclosed
EP-1172356-B1 Process for producing N-acylnitroaniline derivative SUMITOMO CHEMICAL CO (JP) 2004-10-06 EP disclosed
US-6630598-B2 Reacting nitroaniline compound with acid chloride/anhydride in presence of alkali metal/earth metal compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-10-07 US disclosed
EP-0758327-B1 PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS UPJOHN CO (US) 2003-04-09 EP disclosed
US-20020016506-A1 Process for producing N-acylnitroaniline derivative SUMITOMO CHEMICAL COMPANY, LIMITED 2002-02-07 US disclosed
EP-1172356-A1 Process for producing N-acylnitroaniline derivative SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-01-16 EP disclosed
US-6169181-B1 HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITORS PHARMACIA & UPJOHN COMPANY 2001-01-02 US disclosed
EP-0640580-B1 Preparation of 3-pentenoic acid and a catalyst therefor DU PONT (US) 1999-03-03 EP disclosed
US-5852195-A Pyranone compounds useful to treat retroviral infections PHARMACIA & UPJOHN COMPANY (US) 1998-12-22 US disclosed
US-5668164-A Process for synthesis of chiral cis-and trans-3-amino-4 substituted pyrrolidine compounds ABBOTT LABORATORIES (US) 1997-09-16 US disclosed
EP-0791393-A1 Palladium catalyst recovery E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-08-27 EP disclosed
US-5618949-A Process for synthesis of chiral cis- and trans-3-amino-4-substituted pyrrolidine compounds ABBOTT LABORATORIES (US) 1997-04-08 US disclosed
EP-0758327-A1 PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA &amp; UPJOHN COMPANY (US) 1997-02-19 EP disclosed
US-5550161-A COMPOUNDS WHICH CHELATE IRON AND ALUMINUM IONS; TREATMENT OF VARIOUS ANEMIAS, HEMOSIDEROSIS, ALZHEIMER*S DISEASE ORAL-D (US) 1996-08-27 US disclosed
WO-1995030670-A2 PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-16 WO disclosed
EP-0640580-A1 Preparation of 3-pentenoic acid and a catalyst therefore E.I. DU PONT DE NEMOURS AND COMPANY (US) 1995-03-01 EP disclosed
US-5288903-A Catalytic reaction of chlorobutenes with carbon monoxide to pentenoyl chloride; forming palladium catalyst; reacting with butadiene, water to acid E. I. DU PONT DE NEMOURS AND COMPANY (US) 1994-02-22 US disclosed
WO-1992020227-A1 SUBSTITUTED ORALLY EFFECTIVE ION CHELATORS RELATED TO DEFEROXAMINE ORAL-D (US) 1992-11-26 WO disclosed
US-5047421-A Treating trivalent metal overload conditions in humans ORAL-D (US) 1991-09-10 US disclosed
US-5015664-A Orally effective ion chelators related to deferoxamine ORAL D (US) 1991-05-14 US disclosed
US-4738978-A ANTICOAGULANT, ANTIALLERGENS E. R. SQUIBB & SONS, INC. (US) 1988-04-19 US disclosed
US-4684482-A DEFEROXAMINE DERIVATIVES ORAL-D (L.P.) (US) 1987-08-04 US disclosed
US-4671901-A DIFEROXAMINE DERIVATIVES FOR REDUCTION OF METAL ION TUSSUE OV ERLOAD ORAL-D (US) 1987-06-09 US disclosed
EP-0171414-A1 ORALLY EFFECTIVE ION CHELATORS RELATED TO DEFEROXAMINE. ORAL D (US) 1986-02-19 EP disclosed
US-4565764-A COLORED CORE MATERIAL COATED WITH RESIN WALLS CANON KABUSHIKI KAISHA (JP) 1986-01-21 US disclosed
WO-1985003290-A1 ORALLY EFFECTIVE ION CHELATORS RELATED TO DEFEROXAMINE ORAL-D (US) 1985-08-01 WO disclosed
US-4426382-A HYPOTENSIVE AGENTS SANKYO COMPANY LIMITED (JP) 1984-01-17 US disclosed
US-4419356-A 2,3,6,7-Tetrahydrothiazolo[3,2-a]pyrimidine derivatives having anti-rheumatic properties and pharmaceutical compositions containing them RHONE-POULENC INDUSTRIES (FR) 1983-12-06 US disclosed
US-4151179-A ANTIINFLAMMATORY AGENTS FISONS LIMITED (GB) 1979-04-24 US disclosed
US-4151179-A ANTIINFLAMMATORY AGENTS FISONS LIMITED (GB) 1979-04-24 US disclosed